Ai-based risk check for upper digestive tract cancer
Part of Cancer, Digestive system clinical trials.
This study uses an AI tool to help predict the risk of cancer in the upper digestive tract (the esophagus and stomach) based on endoscopy images. It could help you and your doctor catch early signs of cancer during a routine exam.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for or have recently had an upper endoscopy (a test to look at your throat, stomach, and upper intestine).
- You have had an H. pylori infection in the past or currently (a common stomach bacteria).
- You have stomach-related symptoms such as indigestion, pain, or heartburn.
- You have had cancer of the mouth, throat, or voice box in the past.
- You have a condition called Barrett's esophagus, or have precancerous changes in your stomach lining.
- You have a growth or lesion in your stomach.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an AI system helps endoscopy doctors better identify a stomach condition called gastric intestinal metaplasia. It is for endoscopists who already do many image-enhanced endoscopy procedures and are new to this study.
This trial checks whether an artificial intelligence (computer) system can help diagnose Helicobacter pylori (a common stomach bacteria) and early stomach “premalignant” changes using endoscopy results. It may help doctors spot problems more accurately when you have a scheduled scope.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study tests an artificial intelligence tool that analyzes images taken during stomach endoscopy to help diagnose early-stage stomach cancer or precancerous changes. The goal is to improve how doctors identify and treat these lesions early, when treatment is most effective.
This trial uses artificial intelligence during upper endoscopy to help doctors spot signs of stomach cancer earlier. It's for people over 60 who are having an endoscopy due to high-risk symptoms.
This trial tests if an artificial intelligence program can help doctors better detect certain pre-cancerous changes in the stomach lining during an advanced endoscopy procedure. It may benefit people at average risk who are already scheduled for this type of exam.
Hear when a new Premalignant Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.